Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8838765 | Brain Research Bulletin | 2018 | 7 Pages |
Abstract
Vortioxetine is a novel antidepressant capable of improving depressive and cognitive symptoms associated with major depressive disorder (MDD). This study established whether treatment with vortioxetine, fluoxetine or vehicle alters the modulation of brain-derived neurotrophic factor (BDNF) under the 21-day chronic unpredictable mild stress (CUMS) condition in 54 Sprague-Dawley rats. Vortioxetine mitigated the reduction in rearing behavior by CUMS in the OFT on day 7 and 21, as well as sucrose preference on day 21. Histological examination by H&E staining showed that most hippocampal neurons in the CUMSâ¯+â¯FLU and CUMSâ¯+â¯VOR groups were intact, although some of them demonstrated karyopyknosis. The mean optical density value of hippocampal BDNF was significantly higher in the CUMSâ¯+â¯VOR group than the CUMS and CUMSâ¯+â¯FLU groups. There was a trend towards a higher number of hippocampal BDNF-positive cells in the CUMSâ¯+â¯VOR group, although it did not reach statistical significance. In conclusion, vortioxetine, but not fluoxetine, increased hippocampal BDNF levels in rats subject to CUMS.
Keywords
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Yanxia Lu, Cyrus S. Ho, Roger S. McIntyre, Wei Wang, Roger C. Ho,